Tryptophan Metabolism in Kidney Disease
NCT00758537 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2009-07-14
Summary
Tryptophan metabolism in kidney disease will be investigated in patients with chronic kidney disease stages (ADOQI 3-5). Tryptophan levels and respective catabolites will be assessed under hemodialysis.
Conditions
Sponsors & Collaborators
-
Charite University, Berlin, Germany
lead OTHER
Principal Investigators
-
Petra Reinke, Md PhD · Charite University Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-01-31
- Completion
- 2008-10-31
Countries
- Germany
Study Locations
More Related Trials
-
Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury
NCT07197957 ·Status: RECRUITING
-
Chronic Kidney Disease Screening
NCT07153432 ·Status: RECRUITING
-
Effect of a Pre-interventional Diet on Renal Function After Administration of Contrast Agent in Patients at Risk
NCT01879839 ·Status: COMPLETED ·Phase: PHASE4
-
Aortic Calcification and Central Blood Pressure in Patients With Chronic Kidney Disease
NCT04114695 ·Status: COMPLETED
-
ADPKD Alterations in Hepatic Transporter Function
NCT03717883 ·Status: COMPLETED
-
Impact on Mortality of Screening for Kidney Disease Associated With a Specialized Intervention During Hospitalization in a Territorial Hospital Trust
NCT05033652 ·Status: UNKNOWN ·Phase: NA
-
CENtral Blood Pressure Targeting: A Pragmatic RAndomized Pilot triaL in Advanced Chronic Kidney Disease
NCT05163158 ·Status: COMPLETED ·Phase: NA
-
Dcr3 Levels in Blood and Urine on Renal and Patient Prognosis in Patients With Acute Kidney Injury
NCT05735093 ·Status: UNKNOWN
-
Uric Acid and Long-term Outcomes in Chronic Kidney Disease
NCT01158911 ·Status: COMPLETED
-
Acute Kidney Injury and Acute Kidney Disease in COVID-19
NCT04353583 ·Status: COMPLETED
-
Accelerated Immunosenescence and Chronic Kidney Disease
NCT02116270 ·Status: COMPLETED ·Phase: NA
-
Early Screening and Diagnosis of CKD
NCT02841371 ·Status: RECRUITING
-
The CPH-MBD Cohort
NCT07193056 ·Status: NOT_YET_RECRUITING
-
Cardiorenal and Metabolic Effects of Nighttime Eating
NCT06588088 ·Status: COMPLETED ·Phase: NA
-
Chronic Arterial Disease, Quality of Life and Mortality in Chronic Kidney Injury
NCT04223726 ·Status: ACTIVE_NOT_RECRUITING
-
A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life
NCT04034992 ·Status: COMPLETED
-
Development of Early Diagnostic Techniques and Setup of Local Therapeutic Guidelines and Standards
NCT00912704 ·Status: COMPLETED
-
REVEAL-CKD: Prevalence and Consequences of Undiagnosed Chronic Kidney Disease
NCT04847531 ·Status: COMPLETED
-
Chronic Kidney Disease at Northeast Taiwan: Biomarker and Multidisciplinary Care
NCT04300387 ·Status: UNKNOWN ·Phase: NA
-
Risk of Chronic Kidney Disease Progression
NCT02654756 ·Status: COMPLETED
-
Prevalence of Antiphospholipid Antibodies in the Hemodialysis Patients Population Within the CHU Brugmann Hospital
NCT03893357 ·Status: COMPLETED
-
Klotho in Chronic Kidney Disease-associated Pruritis (CKD-aP)
NCT03532568 ·Status: UNKNOWN ·Phase: NA
-
Energy Expenditure in Chronic Kidney Disease
NCT03358966 ·Status: COMPLETED
-
Aortic Stiffness in Chronic Kidney Disease Stage 2 to 4
NCT01279460 ·Status: COMPLETED
-
Factors Influencing Risk of Progression of Chronic Kidney Disease
NCT03954470 ·Status: COMPLETED